BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 34132076)

  • 21. Cerebral Blood Flow Improvement after Indirect Revascularization for Pediatric Moyamoya Disease: A Statistical Analysis of Arterial Spin-Labeling MRI.
    Blauwblomme T; Lemaitre H; Naggara O; Calmon R; Kossorotoff M; Bourgeois M; Mathon B; Puget S; Zerah M; Brunelle F; Sainte-Rose C; Boddaert N
    AJNR Am J Neuroradiol; 2016 Apr; 37(4):706-12. PubMed ID: 26585258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASL-MRI-guided evaluation of multiple burr hole revascularization surgery in Moyamoya disease.
    Lewén A; Fahlström M; Borota L; Larsson EM; Wikström J; Enblad P
    Acta Neurochir (Wien); 2023 Aug; 165(8):2057-2069. PubMed ID: 37326844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Three-dimensional pseudo-continuous arterial spin labeling for evaluation of cerebral hemodynamic changes after revascularization in adult patients with moyamoya disease].
    Zha X; Zhao X; Xu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):483-487. PubMed ID: 37087595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
    Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
    Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring Posterior Cerebral Perfusion Changes With Dynamic Susceptibility Contrast-Enhanced Perfusion MRI After Anterior Revascularization Surgery in Pediatric Moyamoya Disease.
    Seo YS; Lee S; Choi YH; Cho YJ; Lee SB; Cheon JE
    Korean J Radiol; 2023 Aug; 24(8):784-794. PubMed ID: 37500579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of 3D Arterial Spin Labeling and Multi-Parametric Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors.
    Khashbat Md D; Abe Md T; Ganbold Md M; Iwamoto Md S; Uyama Md N; Irahara Md S; Otomi Md PhD Y; Harada Md PhD M; Kageji Md PhD T; Nagahiro Md PhD S
    J Med Invest; 2016; 63(3-4):175-81. PubMed ID: 27644554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
    Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
    Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging.
    Wang R; Yu S; Alger JR; Zuo Z; Chen J; Wang R; An J; Wang B; Zhao J; Xue R; Wang DJ
    Eur Radiol; 2014 May; 24(5):1135-44. PubMed ID: 24557051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periprocedural arterial spin labeling and dynamic susceptibility contrast perfusion in detection of cerebral blood flow in patients with acute ischemic syndrome.
    Nael K; Meshksar A; Liebeskind DS; Wang DJ; Ellingson BM; Salamon N; Villablanca JP;
    Stroke; 2013 Mar; 44(3):664-70. PubMed ID: 23391773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial spin labeling as an ancillary assessment to postoperative conventional angiogram in pediatric moyamoya disease.
    Lang SS; Tucker AM; Schreiber C; Storm PB; Liu H; Li Y; Ichord R; Beslow LA; Sedora-Roman NI; Cox M; Nasser H; Vossough A; Fisher MJ; Kilbaugh TJ; Huh JW
    J Neurosurg Pediatr; 2022 Jan; 29(1):40-47. PubMed ID: 34598159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [
    Fan AP; Khalighi MM; Guo J; Ishii Y; Rosenberg J; Wardak M; Park JH; Shen B; Holley D; Gandhi H; Haywood T; Singh P; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2019 Feb; 50(2):373-380. PubMed ID: 30636572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short- and Long-Term MRI Assessed Hemodynamic Changes in Pediatric Moyamoya Patients After Revascularization.
    Zhao MY; Tong E; Duarte Armindo R; Fettahoglu A; Choi J; Bagley J; Yeom KW; Moseley M; Steinberg GK; Zaharchuk G
    J Magn Reson Imaging; 2024 Apr; 59(4):1349-1357. PubMed ID: 37515518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction for Susceptibility Distortions Increases the Performance of Arterial Spin Labeling in Patients with Cerebrovascular Disease.
    Madai VI; Martin SZ; von Samson-Himmelstjerna FC; Herzig CX; Mutke MA; Wood CN; Thamm T; Zweynert S; Bauer M; Hetzer S; Günther M; Sobesky J
    J Neuroimaging; 2016 Jul; 26(4):436-44. PubMed ID: 26902457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the contribution of individual arteries to the cerebral blood supply in patients with Moyamoya angiopathy: comparison of vessel-encoded arterial spin labeling and digital subtraction angiography.
    Zerweck L; Pohmann R; Klose U; Martirosian P; Haas P; Ernemann U; Khan N; Roder C; Hauser TK; Hennersdorf F
    Neuroradiology; 2024 Jul; 66(7):1131-1140. PubMed ID: 38492021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
    Bian H; Zhang L; Wang J
    Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide.
    Federau C; Christensen S; Zun Z; Park SW; Ni W; Moseley M; Zaharchuk G
    Neuroradiology; 2017 Jan; 59(1):5-12. PubMed ID: 27913820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
    Ma H; Wang Z; Xu K; Shao Z; Yang C; Xu P; Liu X; Hu C; Lu X; Rong Y
    Exp Ther Med; 2017 Jun; 13(6):2691-2698. PubMed ID: 28587332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.